Comparing Acutus Medical (NASDAQ:AFIB) and Vivos (OTCMKTS:RDGL)

Acutus Medical (NASDAQ:AFIBGet Free Report) and Vivos (OTCMKTS:RDGLGet Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Valuation & Earnings

This table compares Acutus Medical and Vivos’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Acutus Medical $7.16 million 0.20 -$81.66 million N/A N/A
Vivos $20,000.00 4,868.45 -$2.89 million ($0.01) -23.70

Vivos has lower revenue, but higher earnings than Acutus Medical.

Risk and Volatility

Acutus Medical has a beta of 0.03, indicating that its share price is 97% less volatile than the S&P 500. Comparatively, Vivos has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for Acutus Medical and Vivos, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Acutus Medical 0 0 0 0 N/A
Vivos 0 0 0 0 N/A


This table compares Acutus Medical and Vivos’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Acutus Medical -166.79% -54.97% -13.82%
Vivos -9,524.89% N/A -201.99%

Insider and Institutional Ownership

56.9% of Acutus Medical shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 18.5% of Vivos shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


Vivos beats Acutus Medical on 5 of the 9 factors compared between the two stocks.

About Acutus Medical

(Get Free Report)

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

About Vivos

(Get Free Report)

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with's FREE daily email newsletter.